AstraZeneca vaccine benefits “increase with age“

AstraZeneca vaccine benefits “increase with age“

The EU's drug watchdog said Friday that a review of AstraZeneca's Covid-19 vaccine found its benefits increase with age and still outweigh the risks for adults despite links to blood clots.The European Medicines Agency (EMA) was presenting its findings after the European Commission asked it to look into concerns that prompted several countries to restrict its use to older people.“It showed that the benefits of vaccination increase with increasing age and infection rates,” the Amsterdam-based EMA said in statement.“The benefits of Vaxzevria outweigh its risks in adults of all age groups; however, very rare cases of blood clots with low blood platelets have occurred following vaccination,” it added, using the vaccine's brand name.The rare clots happened in around one in 100,000 people who received the vaccine, it said.Comments Read Next3 days agoSaudi: Seven blood clots maybe linked to AstraZeneca4 days agoIndia opens up COVID-19 vaccines to all adults in May4 days agoSinopharm vaccine “over 90% effective at preventing hospitalisation”5 days agoAround 20% of Kuwait's population received COVID-19 vaccine1 week agoKuwait plans to vaccinate one million people by end of Ramadan1 week agoThird dose of COVID-19 vaccine likely needed within one year1 week agoKuwait: All mosque workers get COVID-19 jabs2